NCT00006452 Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT00006388 Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00006386 Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00006368 Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Status COMPLETED Phase PHASE1
NCT00006358 Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor Status COMPLETED Phase PHASE2
NCT00006355 Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme Status COMPLETED Phase PHASE1/PHASE2
NCT00006353 Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE3
NCT00006342 Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor Status COMPLETED Phase N/A
NCT00006268 Immunotoxin Therapy in Treating Patients With Malignant Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT00006263 Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma Status WITHDRAWN Phase PHASE2
NCT00006258 Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma Status COMPLETED Phase PHASE2
NCT00006247 SU5416 in Treating Children With Recurrent or Progressive Brain Tumors Status TERMINATED Phase PHASE1
NCT00006246 Busulfan in Treating Children and Adolescents With Refractory CNS Cancer Status COMPLETED Phase PHASE1
NCT00006119 Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma Status COMPLETED Phase PHASE2
NCT00006102 Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00006093 EMD 121974 in Treating Patients With Progressive or Recurrent Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT00006080 Fenretinide in Treating Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE2
NCT00006025 Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE1
NCT00005976 Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma Status COMPLETED Phase PHASE2
NCT00005955 Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors Status COMPLETED Phase PHASE2